National Bank of Canada FI Has $99.79 Million Stock Holdings in CME Group Inc. $CME

National Bank of Canada FI increased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 6.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 362,066 shares of the financial services provider’s stock after purchasing an additional 21,956 shares during the quarter. National Bank of Canada FI owned 0.10% of CME Group worth $99,788,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CME. Jessup Wealth Management Inc increased its position in shares of CME Group by 0.5% during the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after acquiring an additional 36 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in CME Group by 0.7% in the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after purchasing an additional 36 shares during the period. Great Lakes Advisors LLC increased its holdings in CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock worth $441,000 after purchasing an additional 37 shares in the last quarter. MBM Wealth Consultants LLC raised its stake in shares of CME Group by 2.7% in the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after purchasing an additional 37 shares during the period. Finally, Beaumont Financial Advisors LLC raised its stake in shares of CME Group by 2.0% in the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after purchasing an additional 38 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insiders Place Their Bets

In other CME Group news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This represents a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 2,147 shares of company stock worth $562,079. Company insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the subject of several recent research reports. TD Cowen upped their price objective on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a research report on Thursday, October 23rd. Argus reduced their price target on CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a report on Tuesday, October 14th. Rothschild & Co Redburn increased their target price on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday, November 6th. Finally, Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $290.00.

View Our Latest Analysis on CME

CME Group Price Performance

NASDAQ:CME opened at $273.55 on Monday. CME Group Inc. has a 1-year low of $224.62 and a 1-year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a fifty day simple moving average of $271.85 and a 200 day simple moving average of $272.22. The stock has a market capitalization of $98.64 billion, a PE ratio of 26.51, a P/E/G ratio of 4.08 and a beta of 0.28.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. During the same period in the prior year, the firm posted $2.68 earnings per share. The company’s quarterly revenue was down 3.0% compared to the same quarter last year. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is 48.45%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.